{"database": "lobbying", "table": "lobbying_activities", "rows": [[1658891, "8a7fd130-f8ee-4f95-af90-00e2c60d9548", "Q1", "ROBERT ARMITAGE", 401103512, "ELI LILLY AND COMPANY", 2015, "first_quarter", "CPT", "Biopharmaceutical-related IP protection issues, including those associated with the MODDERN Cures Act (H.R. 3116, 113th Cong.),Dormant Therapies Act (S. 3004, 113th Cong.), and The Innovation Act (H.R. 9, 114th Cong.).", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2015-04-13T08:34:16.083000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1658891"], "units": {}, "query_ms": 0.5749599949922413, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}